Dow Chemical has reported its second quarter figures, its seventh consecutive quarter of growth, according to the company.
The materials giant reported sales of $14.9bn (€11.08bn), up 2% on the same period last year with increases across all operating segments. Earnings before interest, tax, depreciation and amortisation (Ebitda) grew to $2.2bn (€1.6bn).
Andrew Liveris, Dow's chairman and chief executive, said: "Our results reflect excellent progress against Dow's near-term priorities and clearly illustrate our ongoing drive to execute self-help actions that are delivering growth on both the top and bottom line.”
As part of its ongoing realignment Dow has earmarked its epoxy business and some chlorine and derivatives assets for sale. It is also looking to sell parts of its functional materials and performance materials units, it said.